BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6315421)

  • 1. Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin.
    van Asbeck BS; Marcelis JH; van Kats JH; Jaarsma EY; Verhoef J
    Eur J Clin Microbiol; 1983 Oct; 2(5):432-8. PubMed ID: 6315421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid.
    van Asbeck BS; Marcelis JH; Marx JJ; Struyvenberg A; van Kats JH; Verhoef J
    Eur J Clin Microbiol; 1983 Oct; 2(5):426-31. PubMed ID: 6416837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical bacteriological studies on cefotiam and cefsulodin in the field of otorhinolaryngology].
    Deguchi K; Fukayama S; Nishimura Y
    Jpn J Antibiot; 1982 May; 35(5):1187-98. PubMed ID: 6290705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antibacterial activity of a siderophore. 3. The activity of deferoxamine in vitro and its influence on the effect of antibiotics against Escherichia coli, Proteus mirabilis and coagulase-negative staphylococci.
    Hartzen SH; Frimodt-Møller N; Thomsen VF
    APMIS; 1994 Mar; 102(3):219-26. PubMed ID: 8185889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
    Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
    Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin: in vitro studies.
    Kirby WM; Standiford HC
    J Infect Dis; 1969; 119(4):361-3. PubMed ID: 4977994
    [No Abstract]   [Full Text] [Related]  

  • 7. The antibacterial activity of a siderophore. 2. The influence of deferoxamine alone and combined with ascorbic acid on the activity of antibiotics against Staphylococcus aureus.
    Hartzen SH; Frimodt-Møller N; Thomsen VF
    APMIS; 1991 Oct; 99(10):879-86. PubMed ID: 1930961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro efficacy of cefotiam in combination with four aminoglycosides on staphylococci and Gram-negative bacteria.
    Daschner FD; Steffens A; Schneider H
    J Antimicrob Chemother; 1981 Sep; 8(3):239-41. PubMed ID: 6270053
    [No Abstract]   [Full Text] [Related]  

  • 10. Cefotaxime, cephalothin, and cephapirin: antimicrobial activity and synergy studies of cephalosporins with significant in vivo desacetyl metabolite concentrations.
    Jones RN; Packer RR
    Diagn Microbiol Infect Dis; 1984 Jan; 2(1):65-8. PubMed ID: 6100364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.
    Appelbaum PC; Tamim J; Pankuch GA; Aber RC
    Chemotherapy; 1983; 29(5):337-44. PubMed ID: 6311492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combination of cefsulodin and mecillinam.
    Kondo M; Tsuchiya K
    J Antibiot (Tokyo); 1981 Jun; 34(6):727-38. PubMed ID: 6268593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gentamycin].
    Wieser T
    Arzneimittelforschung; 1969 May; 19(5):778-80. PubMed ID: 4979307
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of gentamicin and other antibiotics on the pathogenic germs in urinary tract infections (author's transl)].
    Schmid W
    Med Klin; 1973 Dec; 68(50):1652-6. PubMed ID: 4205807
    [No Abstract]   [Full Text] [Related]  

  • 15. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
    Husson MO; Izard D; Leclerc H
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
    Acred P; Ryan DM; Sowa MA; Watts CM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Resistance spectrum of various bacteria against cefotiam in 3 Berlin clinics].
    Hahn H; Wagner J
    Immun Infekt; 1983 Jun; 11(4):140-2. PubMed ID: 6099820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
    Uete T; Matsuo K
    Jpn J Antibiot; 1995 Mar; 48(3):402-8. PubMed ID: 7752453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
    Husson MO; Izard D; Leclerc H
    Drugs Exp Clin Res; 1986; 12(4):325-7. PubMed ID: 3459642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentamicin resistance in Christchurch hospitals.
    Faoagali JL
    N Z Med J; 1979 Jun; 89(637):426-9. PubMed ID: 381994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.